Aquisição de Tocilizumab 162 mg/0.9 ml caneta pré-cheia (Tyenne/FRESENIUS) BIOSSIMILAR, Tocilizumab 20 mg/ml Sol inj Fr 10 ml IV ((Tyenne/FRESENIUS) BIOSSIMILAR e Tocilizumab 20 mg/ml Sol inj Fr 4 ml IV (Tyenne/FRESENIUS) BIOSSIMILAR

ID 11461043 · Portal BASE
Price
Base Price
€146,245 .00
Effective Price
€146,245 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33690000
Location
Portugal, Viana do Castelo, Viana do Castelo
Bidder Count
—
Winner
FRESENIUS KABI PHARMA PORTUGAL LDA
NIF 504293753
Company
Dates
Publication
23 May 2025
Celebration
03 Apr 2025
Contracting Entity
Unidade Local de Saúde do Alto Minho, E. P. E.
NIF 508786193
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 75 · HIGH RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
23 May 2025
Signing Date
03 Apr 2025
Days Late
50
Rule
A2/A3 late publication: 50 days after signing (threshold: 10)
Detected 2026-03-06
A5 · Threshold Splitting
A5_THRESHOLD_SPLITTING
MEDIUM
Base price
146245.0
Threshold
150000.0
Rule
A5 threshold splitting: price within 5% below 150000.0
Detected 2026-03-06